p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin

Cancer

Volumn 73, Issue 9, 1994, Pages 2317-2323

  Lee, Yoke‐Sun ^a   Teh, Meng ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

cell differentiation; fibroblast; keratoacanthoma; neoplasm; p53 expression; pseudoepitheliomatous hyperplasia; skin; squamous cell carcinoma

Indexed keywords

PROTEIN P53;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATOACANTHOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; DERMATITIS; EPIDERMIS; EPITHELIUM; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; HYPERPLASIA; KERATINOCYTES; KERATOACANTHOMA; PROTEIN P53; SKIN; SKIN NEOPLASMS;

EID: 0028173707     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940501)73:9<2317::AID-CNCR2820730913>3.0.CO;2-0     Document Type: Article

References (27)

1. Widespread p53 overexpression in human malignant tumors
2. Overexpression of p53 protein in basal cell carcinomas of human skin
3. Mutant p53 protein is expressed in Bowen's disease
4. Aberrant expression of p53 tumour‐suppressor protein in non‐melanoma skin cancer
5. Expression of mutant p53 in melanoma
6. Expression of p53 protein in cutaneous melanoma
7. Mutant p53 expression in solar keratosis: an immunohistochemical study
8. p53 protein expression in non‐neoplastic lesions and benign and malignant neoplasms of soft tissue
9. Actinic keratoacanthoma: speculations on the nature of the lesion and the role of cellular immunity in its evolution
10. Mutations in the p53 gene occur in diverse human tumor types
11. The p53 proto‐oncogene can act as a suppressor of transformation
12. A role for sunlight in skin cancer: UV‐induced p53 mutation in squamous cell carcinoma
13. Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells: L. Regulation of p53 expression
14. Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression
15. A gigantic, metastasizing keratoacanthoma
16. Intravascular spread of keratoacanthoma: an alarming but benign phenomenon
17. Solitary keratoacanthoma is a squamous‐cell carcinoma: three examples with metastases
18. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
19. p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix
20. Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses
21. P53 point mutation in HPV negative human cervical carcinoma cell lines
22. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
23. p53 in tumour pathology: can we trust immunocytochemistry?
24. Levels of p53 protein increase with maturation in human hematopoietic cells
25. Participation of p53 protein in the cellular response to DNA damage
26. A deadly inheritance
27. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma